Advances in the treatment of tuberculosis

被引:49
作者
Zhang, Y. [1 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA
关键词
D O I
10.1038/sj.clpt.6100362
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The current 6-month tuberculosis (TB) therapy is suboptimal with significant side effects and a poor patient compliance problem that frequently selects drug-resistant organisms. The increasing drug- resistant TB problem highlights the need to develop new and more effective drugs. Significant progress has been made recently with several new drug candidates currently in clinical trials. Improved understanding of persister biology and development of persister drugs are likely to be important for developing a more effective therapy.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 42 条
[1]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[2]  
[Anonymous], MMWR MORB MORTAL WKL
[3]   Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis [J].
Burman, William J. ;
Goldberg, Stefan ;
Johnson, John L. ;
Muzanye, Grace ;
Eagle, Melissa ;
Mosher, Ann W. ;
Choudhri, Shurjeel ;
Daley, Charles L. ;
Munsiff, Sonal S. ;
Zhao, Zhen ;
Vernon, Andrew ;
Chaisson, Richard E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (03) :331-338
[4]   Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis [J].
Byrne, Sean T. ;
Denkin, Steven M. ;
Zhang, Ying .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (02) :313-316
[5]   ANTIMICROBIAL PROPERTIES OF PYRROLE DERIVATIVES [J].
CASTRO, AJ ;
GALE, GR ;
MEANS, GE ;
TERTZAKA.G .
JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (01) :29-&
[6]  
*CDC, 2005, TARG TUB TEST TREATM
[7]  
De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457
[8]   Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains [J].
Deidda, D ;
Lampis, G ;
Fioravanti, R ;
Biava, M ;
Porretta, GC ;
Zanetti, S ;
Pompei, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :3035-3037
[9]   Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears [J].
Diacon, A. H. ;
Patientia, R. F. ;
Venter, A. ;
van Helden, P. D. ;
Smith, P. J. ;
McIlleron, H. ;
Maritz, J. S. ;
Donald, P. R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) :2994-2996
[10]  
Dubos R.J., 1987, The White Plague: Tuberculosis, Man, and Society